CNC vs COLL · P/E 8.4, rev $163.07B vs P/E 17, rev $181.9M
Centene Corp (CNC) versus Collegium Pharmaceutical Inc (COLL) — a side-by-side from cached financials, not a winner call.
Centene Corp (CNC) is a healthcare plans company listed on US.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CNC revenue for 2024-12-31 was $163.07B. Net income was $3.29B. Revenue was up 5.9% from 2023-12-31 to 2024-12-31. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
CNC currently screens at market cap $28.19B and trailing P/E 8.4. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Not investment advice. Open the CNC and COLL stock pages for the full models.
Not investment advice.